SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,238,216 | -6.3% | 199,096 | -15.0% | 1.08% | +0.7% |
| Q2 2023 | $45,068,359 | -18.3% | 234,170 | -14.1% | 1.07% | -27.6% |
| Q1 2023 | $55,188,462 | +58.5% | 272,576 | +0.6% | 1.48% | +26.5% |
| Q4 2022 | $34,821,070 | -16.1% | 270,960 | -10.6% | 1.17% | -0.3% |
| Q3 2022 | $41,487,000 | -13.0% | 303,200 | +12.6% | 1.17% | -46.1% |
| Q2 2022 | $47,659,000 | +62.5% | 269,353 | +32.3% | 2.18% | +176.2% |
| Q1 2022 | $29,331,000 | -7.4% | 203,613 | -0.6% | 0.79% | +19.5% |
| Q4 2021 | $31,680,000 | -7.4% | 204,918 | +1.7% | 0.66% | +1.7% |
| Q3 2021 | $34,201,000 | -4.7% | 201,423 | -11.4% | 0.65% | +1.9% |
| Q2 2021 | $35,884,000 | -11.2% | 227,286 | -21.9% | 0.64% | -17.1% |
| Q1 2021 | $40,431,000 | -19.1% | 291,164 | +2.0% | 0.77% | -12.2% |
| Q4 2020 | $49,973,000 | – | 285,333 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |